What's new

Welcome to Metatrader MT4 and MT5 Gpl Authority

Join us now to get access to all our Codebase MT4 and MT5 Free Paid Download. MetaTrader is a free application for traders allowing to perform technical analysis and trading operations in the Forex and exchange markets.

Add Codebase

Add Codebase to Our Community

Answer

Answer Questions and Become an Expert on Your Topic

Contact Staff

Our Experts are Ready to Answer your Questions

Regeneron Says Antibody Cocktail Therapy Shows Promise in Hospitalized COVID-19 Patients

N

News Feed

Moderator
Staff member
Joined
Aug 4, 2020
Messages
11,178
Reaction score
0
Points
0


Source: Regeneron

(Reuters) - Regeneron Pharmaceuticals Inc said on Tuesday initial data from an ongoing study of its experimental antibody cocktail for use in hospitalized COVID-19 patients requiring low-flow oxygen shows the therapy was sufficiently effective to warrant continuing the trial.

The drugmaker said in September the cocktail, a combination of two antibodies casirivimab and imdevimab, reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients.

Study participants included those who had produced their own antibodies (seropositive) and those who had not (seronegative).

Seronegative patients treated with the antibody cocktail had a lower risk of death or needing mechanical ventilation, the company said.

Based on these results, the company said an ongoing late-stage study in hospitalized patients will continue.

The U.S. Food and Drug Administration last month issued emergency use authorization for the antibody therapy for use in mild to moderate COVID-19 patients who are not currently hospitalized.

_____

Source:
You do not have permission to view link Log in or register now.
 
shape1
shape2
shape3
shape4
shape7
shape8
Top